Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05998616 · ClinicalTrials.gov registry record · NA

Feasibility of Remote Exercise Training for Hispanics/Latinos With MS

A NA study of Multiple Sclerosis, sponsored by University of Illinois at Chicago.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT05998616: Completed NA study of Multiple Sclerosis, sponsored by University of Illinois at Chicago.

NCT05998616 is a NA study of Multiple Sclerosis that has completed, run by University of Illinois at Chicago. The registered enrollment target is 33 participants, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05998616, a NA study of Multiple Sclerosis, has completed, sponsored by University of Illinois at Chicago.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to investigate the potential benefits of a specially designed exercise program for Hispanics/Latinos with multiple sclerosis (MS). The main questions it aims to answer are: * Can a 4-month remotely-delivered exercise training program improve physical function, symptom management, and quality of life in Hispanics/Latinos with MS? * How do social determinants of health, such as income, education, access to healthcare, and social support, influence the feasibility and effectiveness of the exercise intervention? Participants in this study will engage in a 4-month remotely-delivered exercise training intervention that includes flexibility, or aerobic and resistance exercise training sessions. They will work with experienced coaches who will guide and support them throughout the program. The researchers will compare the participants who receive the exercise intervention with a control group to see if the exercise program leads to significant improvements in physical function, fatigue, mood, and overall well-being for Hispanics/Latinos with MS. The study aims to empower this underserved population and provide insights for future healthcare and research initiatives.

Primary Outcome

Participant retention during the 16-week intervention period, reported as number of randomized participants who completed or did not complete the assigned program by study arm.

Conditions Studied

Interventions

  • BEHAVIORAL Exercise Training Program
  • BEHAVIORAL Flexibility Program

Study Locations (1)

Illinois

  • University of Illinois at Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2024-04-27
Est. Completion 2025-12-31
Phase NA
University of Illinois at Chicago

430 total trials

What the finished NCT05998616 record still lists

NCT05998616 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 585-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (94% lower).

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Exercise Training Program is the first listed.

NCT05998616 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT05998616 about?

NCT05998616 is a clinical study titled "Feasibility of Remote Exercise Training for Hispanics/Latinos With MS". The goal of this clinical trial is to investigate the potential benefits of a specially designed exercise program for Hispanics/Latinos with multiple sclerosis (MS). The main questions it aims to answer are: * Can a 4-month remotely-delivered exercise training program improve physical function, sym...

What is the current status of trial NCT05998616?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-04-27. Estimated completion is 2025-12-31.

What conditions does trial NCT05998616 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

What interventions are being tested in trial NCT05998616?

The interventions under investigation include: Exercise Training Program (BEHAVIORAL), Flexibility Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05998616?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05998616 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05998616's enrollment target sits among peer trials

33 216th of 315 higher than 99 of 315 other Multiple Sclerosis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Multiple Sclerosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02861898 · 33 participants · Phase 1

    Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma

  • NCT04871607 · 33 participants · Phase 2

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

  • NCT05071937 · 33 participants · Phase 2

    ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

  • NCT05168618 · 33 participants · Phase 2

    Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05998616, the US trial registry maintained by the National Library of Medicine. NCT05998616 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.